- Home
- TCRX vs SUUN Comparison
TCRX vs SUUN Comparison
Compare TCRX & SUUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- SUUN
- Stock Information
- Founded
- TCRX 2018
- SUUN 2013
- Country
- TCRX United States
- SUUN Canada
- Employees
- TCRX N/A
- SUUN N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- SUUN
- Sector
- TCRX Health Care
- SUUN
- Exchange
- TCRX Nasdaq
- SUUN Nasdaq
- Market Cap
- TCRX 82.1M
- SUUN 75.1M
- IPO Year
- TCRX 2021
- SUUN N/A
- Fundamental
- Price
- TCRX $1.45
- SUUN $1.50
- Analyst Decision
- TCRX Strong Buy
- SUUN Strong Buy
- Analyst Count
- TCRX 6
- SUUN 1
- Target Price
- TCRX $9.50
- SUUN $6.00
- AVG Volume (30 Days)
- TCRX 669.3K
- SUUN 646.0K
- Earning Date
- TCRX 08-11-2025
- SUUN 08-14-2025
- Dividend Yield
- TCRX N/A
- SUUN N/A
- EPS Growth
- TCRX N/A
- SUUN N/A
- EPS
- TCRX N/A
- SUUN N/A
- Revenue
- TCRX $4,421,000.00
- SUUN $25,798,969.00
- Revenue This Year
- TCRX $159.20
- SUUN $15.42
- Revenue Next Year
- TCRX N/A
- SUUN $62.53
- P/E Ratio
- TCRX N/A
- SUUN N/A
- Revenue Growth
- TCRX N/A
- SUUN N/A
- 52 Week Low
- TCRX $1.02
- SUUN $1.23
- 52 Week High
- TCRX $7.89
- SUUN $6.43
- Technical
- Relative Strength Index (RSI)
- TCRX 46.44
- SUUN 43.83
- Support Level
- TCRX $1.39
- SUUN $1.36
- Resistance Level
- TCRX $1.73
- SUUN $1.84
- Average True Range (ATR)
- TCRX 0.15
- SUUN 0.14
- MACD
- TCRX -0.02
- SUUN 0.03
- Stochastic Oscillator
- TCRX 12.53
- SUUN 39.24
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About SUUN SolarBank Corporation Common Stock
SolarBank Corp is an independent renewable and clean energy project developer and asset operator based in Canada and the United States. It is engaged in the development and operation of solar photovoltaic power generation projects in the province of Ontario and the state of New York. The company operates in two principal geographical areas - Canada and United States with a substantial portion of its overall revenue being generated from United States.